| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Quidel Corporation (NASDAQ: QDEL)
QDEL Technical Analysis
5
| As on 9th Jun 2023 QDEL SHARE Price closed @ 84.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 98.95 & Strong Sell for SHORT-TERM with Stoploss of 114.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
QDELSHARE Price
| Open | 84.75 | Change | Price | % |
| High | 85.37 | 1 Day | 0.12 | 0.14 |
| Low | 84.01 | 1 Week | -0.80 | -0.94 |
| Close | 84.74 | 1 Month | -4.81 | -5.37 |
| Volume | 255300 | 1 Year | -77.01 | -47.61 |
| 52 Week High 174.59 | 52 Week Low 67.49 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| QDEL Daily Charts |
QDEL Intraday Charts |
Whats New @ Bazaartrend |
QDEL Free Analysis |
|
|
QDEL Important Levels Intraday
| RESISTANCE | 87.36 |
| RESISTANCE | 86.52 |
| RESISTANCE | 86.00 |
| RESISTANCE | 85.48 |
| SUPPORT | 84.00 |
| SUPPORT | 83.48 |
| SUPPORT | 82.96 |
| SUPPORT | 82.12 |
QDEL Forecast April 2024
| 4th UP Forecast | 163.25 |
| 3rd UP Forecast | 138.07 |
| 2nd UP Forecast | 122.51 |
| 1st UP Forecast | 106.94 |
| 1st DOWN Forecast | 62.54 |
| 2nd DOWN Forecast | 46.97 |
| 3rd DOWN Forecast | 31.41 |
| 4th DOWN Forecast | 6.23 |
QDEL Weekly Forecast
| 4th UP Forecast | 173.75 |
| 3rd UP Forecast | 145.20 |
| 2nd UP Forecast | 127.56 |
| 1st UP Forecast | 109.91 |
| 1st DOWN Forecast | 59.57 |
| 2nd DOWN Forecast | 41.92 |
| 3rd DOWN Forecast | 24.28 |
| 4th DOWN Forecast | -4.27 |
QDEL Forecast2024
| 4th UP Forecast | 302.84 |
| 3rd UP Forecast | 232.89 |
| 2nd UP Forecast | 189.66 |
| 1st UP Forecast | 146.42 |
| 1st DOWN Forecast | 23.06 |
| 2nd DOWN Forecast | -20.18 |
| 3rd DOWN Forecast | -63.41 |
| 4th DOWN Forecast | -133.36 |
Quidel Corporation ( NASDAQ USA Symbol : QDEL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
QDEL Business Profile
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California. Address: 9975 Summers Ridge Road, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service